Breaking News
FONT-SIZE Plus   Neg
Share SHARE

After-market Movers For May 3 (AIG, LNKD, BAGL, DLB, FSLR, BODY, ALXA)

RELATED NEWS
Trade LNKD now with 

Gainers:

Linkedin Corp. (LNKD: Quote) gained 8 percent to $117.99. The company's first quarter profit and revenues doubled from the year-ago quarter and were above Wall Street view. The company guided second quarter revenue above consensus, while raising its fiscal year 2012 revenue guidance. The company also announced that it agreed to acquire SlideShare, a professional content sharing community, in a transaction valued at approximately $118.75 million.

Einstein Noah Restaurant Group, Inc. (BAGL: Quote) rose 29 percent to $18.10 based on the news that it plans review of strategic alternatives, including a possible business combination or sale of the company. The company's first quarter earnings and revenues improved from the last year quarter.

Dolby Laboratories, Inc. (DLB: Quote) increased 18 percent to $44.49 amidst the news that Microsoft (MSFT) has selected Dolby Digital Plus to create audio experiences for Windows 8 on Tablets And PCs. The company's first quarter profit and revenue increased from the prior year period and also were above Wall Street view.

Decliners:

American International Group, Inc. (AIG: Quote) fell 1 percent to $33.80. The company's first quarter net income attributable to the company and its after-tax operating income surged from the previous year period.

First Solar, Inc. (FSLR: Quote) declined 1 percent $17.90. The company slipped to a loss in its first quarter. Net sales declined from the year-ago quarter and was below consensus. Meanwhile, the company raised its fiscal 2012 earnings per share guidance. The company also announced that it has appointed James Hughes as its Chief Executive Officer.

Body Central Corp. (BODY: Quote) plunged 30 percent to $20.25 as the company expects its second quarter and full fiscal year results below Wall Street view. The company's first quarter earnings per share were in-line with analysts' estimate. Net revenues for the quarter increased 11.8 percent.

Alexza Pharmaceuticals, Inc. (ALXA: Quote) declined 42 percent to $0.35. The company has received a Complete Response Letter from the FDA regarding its New Drug Application for ADASUVE inhalation powder, 5 mg and 10 mg, indicating that the application is not ready for approval in its present form.

Register
To receive FREE breaking news email alerts for LinkedIn Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.